Suchergebnisse - (Subject:"Lopinavir")

PubPharm (7)

1

Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r : OLE-MET substudy

enthalten in: HIV clinical trials | 2017

von Saumoy, M. | Tiraboschi, J. | Ordoñez-Llanos, J. | +6

2

Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine : OLE-LIP Substudy

enthalten in: HIV clinical trials | 2016

von Crespo, M. | Navarro, J. | Martinez-Rebollar, M. | +8

3

Virologic response and safety of the abacavir/lamivudine fixed-dose formulation as part of highly active antiretroviral therapy : analyses of six clinical studies

enthalten in: HIV clinical trials | 2009

von Ha, B. | Liao, Q. | Dix, L. | +1

4

Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks

enthalten in: HIV clinical trials | 2009

von Pulido, F. | Estrada, V. | Baril, J. | +8

5

Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patients

enthalten in: HIV clinical trials | 2008

von Murphy, R. | da Silva, B. | Hicks, C. | +7

6

Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimen

enthalten in: HIV clinical trials | 2007

von Loutfy, M. | Ackad, N. | Antoniou, T. | +16

7

Virologic and immunologic response to a boosted double-protease inhibitor-based therapy in highly pretreated HIV-1-infected patients

enthalten in: HIV clinical trials | 2005

von Smith, G. | Boulassel, M. | Klien, M. | +6

1
[1]